MedTrace Logo

Remote BP Monitoring in the PP Period

NCT03728790 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 213

Last updated 2025-01-01

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to trial remote patient monitoring (RPM) in the postpartum hypertensive population in a randomized control design, with an aim to increase the number of blood pressure measurements taken during the fragile and under-monitored postpartum period and to thereby improve postpartum blood pressure control and reduce severe morbidity and mortality. The investigators plan to compare the number of blood pressures recorded in the first 10 days postpartum between patients who have been enrolled in an RPM trial to those who are being treated with the usual care.

Conditions

  • Hypertensive Disorder of Pregnancy

Interventions

DEVICE

Remote Patient Monitoring

Bluetooth-enabled blood pressure cuff to assess whether this technology helps providers collect more data regarding their patients' blood pressures in the postpartum period.

Sponsors & Collaborators

  • Philips Healthcare

    collaborator INDUSTRY

  • New York Presbyterian Hospital

    collaborator OTHER

  • Columbia University

    lead OTHER

Principal Investigators

  • Leslie Moroz, MD · Columbia University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-09
Primary Completion
2019-07-28
Completion
2020-05-11
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03728790 on ClinicalTrials.gov